levamisole has been researched along with Colorectal Neoplasms in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.25) | 18.7374 |
1990's | 43 (53.75) | 18.2507 |
2000's | 32 (40.00) | 29.6817 |
2010's | 4 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiou, HY; Hsieh, LL; Lai, CY; Sung, FC; Tang, R; Wu, FY; Yeh, CC | 1 |
Boye, K; Dahl, O; Flatmark, K; Frikstad, KA; Jacob, H; Maelandsmo, GM; Nesbakken, A; Nesland, JM | 1 |
Dahl, O; Leh, S; Myklebust, MP; Stanisavljević, L | 1 |
Ghebremichael, M | 1 |
Dahl, O; Elsaleh, H; Fluge, Ø; Knudsen, ES; Leh, S; Li, Z; Myklebust, MP; Myrvold, HE; Pestell, RG; Rui, H; Tran, TH; Tveit, KM; Vonen, B | 1 |
Iacopetta, B | 1 |
Erlichman, C; Hobday, TJ | 1 |
Grinev, MV | 1 |
Comte, S; Lebrun, T; Selke, B | 1 |
Henne-Bruns, D; Link, KH; Staib, L | 1 |
Hwang, YH; Park, SP; Suh, CK | 1 |
Gray, R; Hills, R; Stowe, R | 1 |
Imanishi, T; Kamigaki, T; Kuroda, Y | 1 |
Hirata, K; Nishikawa, N; Sasaki, K; Takasaka, H; Yoshikawa, T | 1 |
Murakami, M; Naito, M; Ota, T; Shimizu, N; Tsukuda, K | 1 |
Gal, R; Klein, B; Koren, R; Sadikov, E; Sulkes, J | 1 |
Scheithauer, W | 1 |
Haller, DG; Sun, W | 1 |
Agnese, V; Bazan, V; Calò, V; Cicero, G; Colucci, G; Corsale, S; Dardanoni, G; Gebbia, N; Grassi, N; Latteri, MA; Russo, A; Tomasino, RM; Valerio, MR; Vieni, S | 1 |
Arnaud, JP; Baila, L; Bedenne, L; Bleiberg, H; Bouché, O; Conroy, T; Debois, M; Grobost, O; Guimares dos Santos, J; Lacourt, J; Lasser, P; Mackiewickz, R; Morin, T; Nordlinger, B; Ollier, JC; Rougier, P; Seitz, JF; van Cutsem, E; Wals, J; Wils, J | 1 |
Adamo, V; Bianco, AR; Carlomagno, C; Cortesi, E; De Placido, S; De Vita, F; Farris, A; Ficorella, C; Gallo, C; Gebbia, N; Gemini, M; Iannace, C; Ianniello, GP; Lopez, M; Manzione, L; Palazzo, S; Palmeri, S; Paoletti, G; Perrone, F; Persico, G; Pistillucci, G | 1 |
Albertsson, M; Bentzen, SM; Cedermark, B; Dahl, O; Glimelius, B; Grönberg, H; Hultborn, R; Jakobsen, A; Påhlman, L; Starkhammar, H; Tveit, KM | 1 |
Cheng, Y; Shen, Y | 1 |
Barnwell, J; Gray, R; Hills, RK; Kerr, DJ; McConkey, C; Williams, NS | 1 |
Bjørge, L; Matre, R | 1 |
Abdalla, EE; Adam, IJ; Blair, GE; Boylston, A; Finan, P; Johnston, D; Sue-Ling, HM | 1 |
Dobranowski, J; Fawcet, SE; Figueredo, AT; Molloy, DW; Paulseth, JE | 1 |
Stenram, U | 1 |
Reynolds, T | 1 |
AbdAlla, EE; Blair, GE; Johnston, D; Jones, RA; Sue-Ling, HM | 1 |
Leicester, RJ; Mansi, JL; Rayter, Z | 1 |
Fassas, AB; Gattani, AM; Morgello, S | 1 |
Beerblock, K; de Gramont, A; Demuynck, B; Grangé, JD; Krulik, M; Louvet, C; Navarro-Carola, E; Soubrane, D; Varette, C | 1 |
Chlebowski, RT; Lillington, L; Nystrom, JS; Sayre, J | 1 |
Cassidy, J | 1 |
Schmoll, HJ | 1 |
Nordlinger, B; Rougier, P | 1 |
Alvarez, X; Goodrich, KH; Holcombe, RF | 1 |
Slevin, ML | 1 |
Toge, T | 1 |
Bécouarn, Y; Brunet, R; Giovannini, M; Perrier, H; Rouhier, ML; Seitz, JF | 1 |
Wils, J | 1 |
Bonistalli, L; Costantini, M; Messori, A; Tendi, E; Trallori, G | 1 |
Siderov, J; Simes, J; Zalcberg, JR | 1 |
Norum, J; Olsen, JA; Revhaug, A; Vonen, B | 1 |
Kerr, DJ; Midgley, RS | 1 |
Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Hsu, H; Lin, JK; Lin, TC; Liu, JH; Wang, WS; Yen, CC | 1 |
Haller, DG; Vaughn, DJ | 1 |
Drews, M; Fundowicz, D; Paszkowski, J; Szmeja, J; Wierzbicki, T; Załuski, J | 1 |
Ahnen, DJ; Bunn, PA; Feigl, P; Fenoglio-Preiser, C; Lovato, LC; Macdonald, JS; Meyskens, FL; Quan, G; Stemmerman, G; Wells, JD | 1 |
Bandealy, MT; Einhorn, LH; Gonin, R; Loehrer, PJ; Monaco, F | 1 |
Louvet, C | 1 |
Ben Abdesselem, M; Ben Ayed, F; Ben Safta, Z; Benna, F; Boussen, H; Dhouib, R; Dziri, C; el May, M; Gammoudi, A; Hamza, H; Jerbi, G; Kallel, N; Khomsi, F; Najah, N; Rahal, K; Zaouche, A | 1 |
Büchele, T; Dempke, W; Grothey, A; Schmoll, HJ | 1 |
Connolly, M; Ding, C; Gwilt, P; Kremer, A; Tempero, M | 1 |
Schallhorn, A | 1 |
Barnwell, J; Gray, R; Kerr, DJ; McConkey, C | 1 |
Vermorken, JB | 1 |
Cunningham, D; Waters, JS | 1 |
Kodaira, S; Nozawa, K; Shatari, T | 1 |
Bock, PR; Hanisch, J; Kulig, J; Kłek, S; Popiela, T; Wachol, D | 1 |
Barylak, E; Cnaan, A; Harris, JE; Mansour, EG; Schutt, AJ; Witte, RS | 1 |
Kerr, DJ | 1 |
Glimelius, B; Hafström, L; Nygren, P; Ragnhammar, P | 1 |
Maughan, TS | 1 |
Blomgren, H; Edler, D; Glimelius, B; Hallström, M; Jakobsen, A; Johnston, PG; Magnusson, I; Ragnhammar, P | 1 |
Glimelius, B; Påhlman, L | 2 |
Steinke, B | 1 |
Hossfeld, DK | 1 |
Green, M; Wirth, A; Zalcberg, JR | 1 |
Neal, G; Wei, JP | 1 |
Bulger, KN; Hesketh, PJ | 1 |
Schlag, P | 1 |
Friedman, MA; Hamilton, JM; Sznol, M | 1 |
Grem, JL | 2 |
Theve, T | 1 |
Fleming, TR; Gerstner, JB; Krook, JE; Laurie, JA; Leigh, JE; Malliard, J; McCormack, GW; Moertel, CG; Rubin, J; Wieand, HS | 1 |
30 review(s) available for levamisole and Colorectal Neoplasms
Article | Year |
---|---|
Adjuvant therapy of colon cancer: a review.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Immunotherapy; Irinotecan; Leucovorin; Levamisole; Neoplasm Staging | 2002 |
[Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].
Topics: Antineoplastic Agents; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; France; Humans; Irinotecan; Leucovorin; Levamisole; Palliative Care; Quality-Adjusted Life Years; Quinazolines; Thiophenes | 2003 |
[Adjuvant chemotherapy for colorectal cancer: Its efficacy and problems].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Evidence-Based Medicine; Fluorouracil; Humans; Leucovorin; Levamisole; Meta-Analysis as Topic; Treatment Outcome | 2003 |
[Home chemotherapy and outpatient treatment for metastatic colorectal cancer].
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Fatal Outcome; Female; Fluorouracil; Home Care Services; Humans; Infusions, Intravenous; Irinotecan; Levamisole; Liver Neoplasms; Middle Aged; Quality of Life | 2003 |
[Adjuvant chemotherapy for colorectal carcinoma after curative resection].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colectomy; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Evidence-Based Medicine; Fluorouracil; Humans; Leucovorin; Levamisole; Pharmacogenetics; Polymorphism, Genetic; Prognosis | 2003 |
[Advances in palliative and adjuvant chemotherapy of colon cancer].
Topics: Antineoplastic Agents; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Tegafur; Uracil | 2004 |
Adjuvant therapy of colon cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis | 2005 |
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2005 |
Adjuvant chemotherapy for colorectal cancer.
Topics: Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Prognosis | 1995 |
Cerebral demyelination with 5-fluorouracil and levamisole.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Colorectal Neoplasms; Demyelinating Diseases; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged | 1994 |
Colorectal carcinoma: current problems and future perspectives.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Forecasting; Humans; Immunotherapy; Levamisole; Mass Screening; Neoplasm Staging; Portal Vein; Risk Factors | 1994 |
Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Leucovorin; Levamisole; Male; Portal Vein; Rectal Neoplasms; Risk Factors | 1993 |
[Progress of adjuvant chemotherapy in colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Survival Rate | 1996 |
[Immunotherapy of colorectal cancers].
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; BCG Vaccine; Colorectal Neoplasms; Cytokines; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy, Active; Levamisole | 1996 |
The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Levamisole; Randomized Controlled Trials as Topic | 1996 |
Adjuvant treatment of colorectal cancer.
Topics: Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Humans; Immunotherapy; Leucovorin; Levamisole; Randomized Controlled Trials as Topic; Rectal Neoplasms | 1997 |
The role of adjuvant chemotherapy in the treatment of colorectal cancer.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Immunotherapy; Levamisole; Neoplasm Staging; Rectal Neoplasms | 1997 |
[What's new in adjuvant therapy of colorectal cancers?].
Topics: Adjuvants, Immunologic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Prognosis; Treatment Outcome | 1998 |
Where do we stand with 5-fluorouracil?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Chronotherapy; Colorectal Neoplasms; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Interferons; Leucovorin; Levamisole; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Trimetrexate; Zidovudine | 1999 |
[Adjuvant chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic | 2000 |
Adjuvant immunotherapy in colorectal cancer.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; BCG Vaccine; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Humans; Immunization, Passive; Immunotherapy, Active; Levamisole | 2000 |
[Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Mitomycin; Randomized Controlled Trials as Topic; Semustine; Survival Rate; Tegafur; Uracil; Vincristine | 2000 |
A systematic overview of chemotherapy effects in colorectal cancer.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Neoplasm Staging; Palliative Care; Portal Vein; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis | 2001 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
Adjuvant therapy of colorectal cancer: an overview.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole | 1991 |
Levamisole and its use in adjuvant treatment after surgical resection of colorectal cancer.
Topics: Colorectal Neoplasms; Combined Modality Therapy; Humans; Levamisole | 1991 |
Role of adjuvant therapy in colorectal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Radiotherapy | 1991 |
5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemistry, Clinical; Colonic Neoplasms; Colorectal Neoplasms; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Immunity, Cellular; Levamisole; Neoplasm Recurrence, Local; Stimulation, Chemical | 1990 |
Consensus panel considers adjuvant therapy for colon and rectal cancer, identifies levamisole--fluorouracil as standard in colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; United States | 1990 |
Levamisole as a therapeutic agent for colorectal carcinoma.
Topics: Animals; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Levamisole | 1990 |
26 trial(s) available for levamisole and Colorectal Neoplasms
Article | Year |
---|---|
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Decision-Making; Colorectal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Levamisole; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; S100 Calcium-Binding Protein A4; Treatment Outcome; Tumor Cells, Cultured | 2016 |
LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Topics: AC133 Antigen; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Survival Rate; Tissue Array Analysis | 2016 |
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Cyclin D1; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Levamisole; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2012 |
[Interferon-alpha in adjuvant treatment of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levamisole; Neoplasm Staging; Recombinant Proteins; Survival Rate | 2002 |
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Survival Analysis | 2005 |
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2005 |
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Survival Rate | 2005 |
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Vitamin B Complex | 2007 |
Late mortality and levamisole adjuvant therapy in colorectal cancer.
Topics: Aged; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Survival Analysis; Time Factors | 1994 |
Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Leucovorin; Levamisole; Male; Portal Vein; Rectal Neoplasms; Risk Factors | 1993 |
Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Colostomy; Cost-Benefit Analysis; Female; Fluorouracil; Follow-Up Studies; Health Care Costs; Humans; Length of Stay; Levamisole; Male; Middle Aged; Norway; Quality of Life; Survival Analysis; Survival Rate; Travel | 1997 |
Factors predictive of response and survival in patients with metastatic colorectal cancer in Taiwan.
Topics: Adjuvants, Immunologic; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections; Leucovorin; Levamisole; Liver Neoplasms; Male; Middle Aged; Prognosis; Remission Induction; Survival Analysis | 1997 |
[Combined treatment of large bowel cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate | 1997 |
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Topics: Cell Division; Chemotherapy, Adjuvant; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, ras; Genetic Markers; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Ploidies; Polymorphism, Single-Stranded Conformational; Prognosis; Survival Analysis | 1998 |
Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Double-Blind Method; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Prospective Studies; Survival Rate | 1998 |
[Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases)].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 1999 |
Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 2000 |
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2000 |
Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chymotrypsin; Colorectal Neoplasms; Disease-Free Survival; Double-Blind Method; Drug Combinations; Fluorouracil; Humans; Levamisole; Neoplasm Metastasis; Pancreatic Extracts; Papain; Pilot Projects; Quality of Life; Survival Rate; Thymus Extracts; Trypsin | 2000 |
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Treatment Outcome | 2001 |
A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prospective Studies | 2001 |
Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Topics: Adjuvants, Immunologic; Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Thymidylate Synthase; Treatment Outcome | 2002 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
Role of adjuvant therapy in colorectal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Radiotherapy | 1991 |
Levamisole as a therapeutic agent for colorectal carcinoma.
Topics: Animals; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Levamisole | 1990 |
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Patient Compliance; Random Allocation | 1989 |
29 other study(ies) available for levamisole and Colorectal Neoplasms
Article | Year |
---|---|
Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Colorectal Neoplasms; Drug Combinations; ErbB Receptors; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Polymorphism, Genetic; Prognosis; Survival Rate | 2013 |
Nonparametric estimation of mean residual functions.
Topics: Algorithms; Analysis of Variance; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Confidence Intervals; Disease-Free Survival; Fluorouracil; Humans; Levamisole; Placebos; Sample Size; Statistics, Nonparametric; Survival Analysis | 2009 |
A biological perspective on the selection of stage II colorectal cancer patients for adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome | 2002 |
[Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Male; Neoplasm Metastasis; Palliative Care; Quality of Life; Rectum; Time Factors | 2002 |
Multifocal inflammatory leukoencephalopathy: use of thallium-201 SPECT and proton MRS.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Aspartic Acid; Axons; Biopsy; Brain; Brain Neoplasms; Choline; Colorectal Neoplasms; Diagnosis, Differential; Fluorouracil; Humans; Lactic Acid; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Metastasis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2003 |
Anything in modulation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Research Design | 2003 |
Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Carcinoma; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; DCC Receptor; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Receptors, Cell Surface; Survival Analysis; Treatment Outcome; Tumor Suppressor Proteins | 2004 |
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Prospective Studies; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tumor Suppressor Protein p53 | 2005 |
Adaptive design: estimation and inference with censored data in a semiparametric model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Computer Simulation; Confidence Intervals; Data Interpretation, Statistical; Fluorouracil; Levamisole; Neoplasm Recurrence, Local; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2007 |
Down-regulation of CD59 (protectin) expression on human colorectal adenocarcinoma cell lines by levamisole.
Topics: Adenocarcinoma; Adjuvants, Immunologic; CD59 Antigens; Colorectal Neoplasms; Complement Activation; Down-Regulation; Humans; Levamisole; Tumor Cells, Cultured | 1995 |
The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.
Topics: Adjuvants, Immunologic; Colorectal Neoplasms; Enterotoxins; Female; Humans; Levamisole; Lymphocyte Activation; Male; Middle Aged; Phytohemagglutinins; Postoperative Period; T-Lymphocytes; Tuberculin | 1995 |
Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Dementia; Female; Fluorouracil; Humans; Levamisole; Male | 1995 |
Re: Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Fluorouracil; Histocompatibility Antigens Class I; Levamisole; Pilot Projects; Rats; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
Dutch trial casts doubt on colorectal adjuvant therapy.
Topics: Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Drug Therapy, Combination; Europe; Fluorouracil; Humans; Levamisole; Treatment Outcome | 1995 |
Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line.
Topics: beta 2-Microglobulin; Blotting, Northern; Colorectal Neoplasms; DNA Probes; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorouracil; Genes, MHC Class I; Humans; Levamisole; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
[Toxicity of levamisole in adjuvant chemotherapy for colorectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Retrospective Studies | 1993 |
Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; National Institutes of Health (U.S.); United Kingdom; United States | 1994 |
Effect of levamisole on major histocompatibility complex class I expression in colorectal and breast carcinoma cell lines.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Colorectal Neoplasms; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Levamisole; Tumor Cells, Cultured | 1993 |
Adjuvant treatment for colorectal cancer.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Randomized Controlled Trials as Topic | 1996 |
Adjuvant treatment of colorectal cancer in The Netherlands: a commentary.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Netherlands | 1996 |
Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cost-Benefit Analysis; Drug Administration Schedule; Economics, Pharmaceutical; Fluorouracil; Heparin; Humans; Levamisole; Mitomycins; Portal System; Survival Rate | 1996 |
Adjuvant chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Survival Analysis | 2000 |
Adjuvant chemotherapy for colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Levamisole; Microsatellite Repeats; Neoplasm Staging; Prognosis; Treatment Outcome | 2001 |
[Adjuvant therapeutic possibilities in carcinoma of colon and rectum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Colectomy; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole | 1992 |
[Is there a reliable adjuvant (intraoperative) chemotherapy of colorectal cancer?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Staging | 1990 |
[Treatment of colorectal cancer with antineoplastic agents. Too early to introduce routine adjuvant therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Prognosis | 1991 |
[Adjuvant chemotherapy in colonic carcinoma?].
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Postoperative Care | 1991 |
[Is levamisole combined with fluorouracil efficient in colorectal cancer?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local | 1990 |
5-Fluorouracil and levamisole in colorectal carcinoma.
Topics: Adjuvants, Immunologic; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole | 1990 |